Liu Y - Search Results

1

Pegylated liposomal doxorubicin (Duomeisu^®) monotherapy in patients with HER2-negative metastatic breast cancer heavily pretreated with anthracycline and taxanes: a single-arm, phase II study.

Jiang H, Li H, Song G, Di L, Shao B, Yan Y, Liu X, Chen Y, Zhang R, Ran R, Liu Y, Gui X, Wang N, Wang H. Jiang H, et al. Among authors: liu y, liu x. Breast Cancer Res Treat. 2023 May;199(1):67-79. doi: 10.1007/s10549-023-06894-3. Epub 2023 Mar 6. Breast Cancer Res Treat. 2023. PMID: 36877215 Free PMC article. Clinical Trial.

2

Plasma PIK3CA ctDNA specific mutation detected by next generation sequencing is associated with clinical outcome in advanced breast cancer.

Li H, Xu Y, Zhao F, Song G, Rugo HS, Zhang Y, Yang L, Liu X, Shao B, Yang L, Liu Y, Ran R, Zhang R, Guan Y, Chang L, Yi X. Li H, et al. Among authors: liu y, liu x. Am J Cancer Res. 2018 Sep 1;8(9):1873-1886. eCollection 2018. Am J Cancer Res. 2018. PMID: 30323979 Free PMC article.

3

Prognostic Value of Plasma HER2 Gene Copy Number in HER2-Positive Metastatic Breast Cancer Treated with First-Line Trastuzumab.

Ran R, Huang W, Liu Y, Shao L, Liu X, Niu Y, Kong W, Bo S, Rugo HS, Lu S, Li H. Ran R, et al. Among authors: liu y, liu x. Onco Targets Ther. 2020 May 19;13:4385-4395. doi: 10.2147/OTT.S240990. eCollection 2020. Onco Targets Ther. 2020. PMID: 32547071 Free PMC article.

4

Efficacy and Safety of Pyrotinib Versus T-DM1 in HER2+ Metastatic Breast Cancer Patients Pre-Treated With Trastuzumab and a Taxane: A Bayesian Network Meta-Analysis.

Liao H, Huang W, Liu Y, Pei W, Li H. Liao H, et al. Among authors: liu y. Front Oncol. 2021 May 3;11:608781. doi: 10.3389/fonc.2021.608781. eCollection 2021. Front Oncol. 2021. PMID: 34012912 Free PMC article.

5

Multicenter phase II study of apatinib single or combination therapy in HER2-negative breast cancer involving chest wall metastasis.

Li H, Geng C, Zhao H, Jiang H, Song G, Zhang J, Liu Y, Gui X, Wang J, Li K, Tong Z, Zhao F, Yang J, Chen G, Liu Q, Liang X. Li H, et al. Among authors: liu y, liu q. Chin J Cancer Res. 2021 Apr 30;33(2):243-255. doi: 10.21147/j.issn.1000-9604.2021.02.11. Chin J Cancer Res. 2021. PMID: 34158743 Free PMC article.

6

Bilateral breast cancer in China: A 10-year single-center retrospective study (2006-2016).

Jiang H, Zhang R, Liu X, Ran R, Zhang J, Liu Y, Gui X, Chen Y, Li K, Shao B, Yan Y, Liang X, Song G, Di L, Li H. Jiang H, et al. Among authors: liu y, liu x. Cancer Med. 2021 Sep;10(17):6089-6098. doi: 10.1002/cam4.4141. Epub 2021 Aug 4. Cancer Med. 2021. PMID: 34346560 Free PMC article.

7

Activity of preclinical and phase I clinical trial of a novel androgen receptor antagonist GT0918 in metastatic breast cancer.

Li H, Song G, Zhou Q, Ran R, Jiang H, Zhang R, Liu Y, Zhang J, Meng L, Ma L, Sun Y, Wang M, Zhou Q, Yan H, Zhou Q, Dong X, Tong Y. Li H, et al. Among authors: liu y. Breast Cancer Res Treat. 2021 Oct;189(3):725-736. doi: 10.1007/s10549-021-06345-x. Epub 2021 Aug 14. Breast Cancer Res Treat. 2021. PMID: 34392453 Free PMC article. Clinical Trial.

8

Efficacy and Safety of Initial 5 Years of Adjuvant Endocrine Therapy in Postmenopausal Hormone Receptor-Positive Breast Cancer: A Systematic Review and Network Meta-Analysis.

Liao H, Pei W, Zhong J, Shao B, Liu X, Liu Y, Zhang J, Rugo HS, Li H. Liao H, et al. Among authors: liu y, liu x. Front Pharmacol. 2022 May 30;13:886954. doi: 10.3389/fphar.2022.886954. eCollection 2022. Front Pharmacol. 2022. PMID: 35721183 Free PMC article.

9

Prognostic Value of Pretreatment Neutrophil-to-Lymphocyte Ratio in HER2-Positive Metastatic Breast Cancer.

Shao B, Liu X, Li H, Song G, Di L, Jiang H, Yan Y, Zhang R, Ran R, Zhang J, Liu Y, Wang H, Wang J. Shao B, et al. Among authors: liu y, liu x. Curr Oncol. 2022 Aug 25;29(9):6154-6166. doi: 10.3390/curroncol29090483. Curr Oncol. 2022. PMID: 36135052 Free PMC article.

10

Proxalutamide in patients with AR-positive metastatic breast cancer: Results from an open-label multicentre phase Ib study and biomarker analysis.

Jiang H, Ouyang Q, Yin Y, Tong Z, Shen K, Yuan Z, Geng C, Liu Y, Song G, Ran R, Li W, Qu Q, Wang M, Meng L, Tong Y, Li H. Jiang H, et al. Among authors: liu y. Eur J Cancer. 2022 Nov;176:1-12. doi: 10.1016/j.ejca.2022.08.025. Epub 2022 Sep 28. Eur J Cancer. 2022. PMID: 36182805 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

205,031 results

Search Page

Filters